Dr David Davtyan Dba Newhope - 90025 Los Angeles, CA

Business Name: Dr David Davtyan Dba Newhope
Categorized In: Physicians Offices
Address: 11847 Wilshire Boulevard, Los Angeles, CA 90025
Phone Number: (310) 477-1524
Contact Person: David G Davtyan
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2007
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Terry J Dubrow Md Dr - Los Angeles, CA 90025
Silverman Heather MD - Los Angeles, CA 90025
Schwartz Jeffrey MD - Los Angeles, CA 90025
Victor Marder Md - Los Angeles, CA 90025
Skeens Kimberly - Los Angeles, CA 90025
Scott Fox Dr - Los Angeles, CA 90025
Fantel Dr E - Los Angeles, CA 90025
Eyeler Jerry MD - Los Angeles, CA 90025
Kram Leonard MD - Los Angeles, CA 90025
Dr David Davtyan Dba Newh - Los Angeles, CA 90025
Krell Heather MD - Los Angeles, CA 90025
J Kleiner Md - Los Angeles, CA 90025
West Rachel Dr Do Incorporated - Los Angeles, CA 90025
Kar Snehendu Dr - Los Angeles, CA 90025
Geo Berci Md - Los Angeles, CA 90025
Roberts Wendy MD - Los Angeles, CA 90025
Goldberg Alfred Md Incorporated - Los Angeles, CA 90025
Rosenblatt Michael MD - Los Angeles, CA 90025
Viviana Suaya MD - Los Angeles, CA 90025
Smurda Joseph M MD - Los Angeles, CA 90025

Dr David Davtyan Dba Newhope provides professional Physicians Offices from its single location at the coordinates .

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2007, the company can now be visited at 11847 Wilshire Boulevard, Los Angeles, California 90025 or contacted through representative David G Davtyan at (310) 477-1524.

For frequently asked questions and further inquiries about professional Physicians Offices, get to know more about Dr David Davtyan Dba Newhope through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.